Precision treatment for salivary gland cancer
Part of Cancer, Mouth & dental clinical trials.
This trial tests a personalized treatment approach for recurrent or metastatic salivary gland cancer. It uses special tests on your tumor to find the best targeted therapy for your specific cancer type.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with salivary gland cancer (confirmed by a biopsy).
- You are 18 years or older.
- Your daily activity level is fairly good (ECOG score 0 or 1).
- You have at least one tumor that can be measured on scans.
- You do not have serious heart, lung, liver, or kidney problems, or an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, Rezvilutamide, combined with standard hormone therapy for people with a rare and aggressive type of salivary gland cancer that has a high risk of coming back. The treatment aims to reduce the chance of cancer returning after surgery.
This trial uses genetic testing of your tumor to match you with a targeted therapy. It is for people with advanced solid tumors who have exhausted or cannot tolerate standard treatments.
This trial studies toripalimab (an immune medicine) combined with chemotherapy given before surgery for salivary gland cancer. It aims to shrink the tumor and improve outcomes by using treatment early, before the operation.
This Phase 2 trial tests how well ado-trastuzumab emtansine (and compares to two standard treatment options) works for salivary gland cancers that are HER2-positive or HER2-low. It aims to see whether the study drug can control cancer better and with acceptable side effects.
This trial studies giving an immunotherapy drug (sintilimab) plus two chemotherapy medicines before surgery to shrink salivary gland cancer. The goal is to improve how well the cancer responds and is controlled, while still aiming for a cure through surgery.
This study tests a combination of a targeted cancer drug (antibody-drug conjugate) and focused radiation therapy for salivary gland cancers that have come back or spread after initial treatment. It may help patients whose cancer didn't respond to standard options.
Hear when a new Precision Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.